The replication of human cytomegalovirus (HCMV) strain AD169 was studied in human peripheral blood granulocytes, monocytes-macrophages, B lymphocytes, and T lymphocytes. Progeny virus was produced in some T-cell cultures stimulated in the allogeneic mixed lymphocyte reaction and was regularly obtained when stimulated T cells were grown in the presence of interleukin 2. Replication of HCMV in these cultures was documented by increases in titer, expression of early and late antigen as assessed by indirect immunofluorescence and Western blot, and viral DNA synthesis as determined by dot-blot assays. Approximately 0.05% of cells in virus-producing cultures formed infectious centers, indicating that only a subset of cells takes part in active virus replication. In double-immunofluorescence experiments this subset was found to consist primarily of the T3+ and T8+ phenotype. By infection of preparatively separated T4+ and T8+ T lymphocytes, however, it could be shown that both T-cell subsets were susceptible to HCMV infection as indicated by increases in titer and by DNA kinetics. We conclude from these data that the T lymphocyte might be a target for HCMV in vitro, which is in accordance with in vivo findings in HCMV-infected patients.
The isolation of human cytomegalovirus (HCMV) from human peripheral blood leukocytes has been documented by workers from various laboratories over more than 10 years. Successful isolation was reported for various leukocyte subpopulations as granulocytes, T lymphocytes, or monocytes (8, 13, 15, 18, 32) . Moreover, Spector et al. recently demonstrated the presence of HCMV DNA in peripheral blood lymphocytes of HCMV-infected patients (42) . It was, however, not clear whether the presence of HCMV in the various leukocyte subpopulations was due to a nonspecific uptake of viral particles, especially in granulocytes, or was representative for virus replication. The in vitro resistance against HCMV infection of human primary mononuclear cells has been documented by Rinaldo et al. (34) , who also described the failure of HCMV to replicate in myeloblastoid cells. St. Jeor and Weisser (43) and Furukuwa (14) , however, reported a limited replication of HCMV in different lymphoblastoid cell lines, whereas Huang and Pagano found replication only in Epstein-Ball virus-positive cell lines (20) . Tocci and St. Jeor have also demonstrated the replication of HCMV in Epstein-Barr virus-negative cell lines (47) .
As already discussed by Rinaldo et al. (34) , the failure of primary human mononuclear cells to replicate HCMV may be caused by a limited survival time of cells held in culture. The recent availability of interleukin 2 (IL-2) (40) may help overcome this problem, at least for T cells.
It has been emphasized that HCMV reactivation in vivo is due to the interaction of histoincompatible cells in patients who have been given transfusions or transplants (22) , and Olding et al. (28) showed that cytomegalovirus may be activated from murine lymphocytes by allogeneic reaction. This prompted us to investigate the comparative replication of HCMV in different human leukocyte subpopulations with special regard to T lymphocytes stimulated in the allogeneic mixed lymphocyte culture (MLC) and grown in the presence of IL-2. Replication of HCMV was observed in some of the MLC-activated T-lymphocyte cultures regardless of the serostatus of the donor and was regularly obtained in T lymphocytes of both the T4 and T8 phenotype, when cultivated with IL-2. Virus replication was documented by viral protein expression, DNA synthesis and generation of infectious progeny virus. The results obtained supported the possible T-cell nature of the viral target cell.
MATERIALS AND METHODS
Cells and virus. For preparation of virus stocks, titration of virus, and performance of infectious center assays, human embryonic lung (HEL) Wi-38 cells were used. Cells were held in basal Eagle medium containing 10% fetal calf serum (FCS), 100 U of penicillin per ml, and 100 ,ug of streptomycin per ml. Cells were subcultured weekly and were free of mycoplasma, as tested by W. Nicklas, German Cancer Research Center, Heidelberg. Virus stocks of HCMV strain AD169 were obtained by serial passages of the virus at low multiplicity of infection (MOI) (0.01) to avoid generation of defective particles (9) . Virus titrations were performed on HEL cells with an overlay of 0.3% agarose (Sigma Chemical Co., Munich, Federal Republic of Germany) in basal Eagle medium containing 10% FCS for 10 days at 37°C under a humidified atmosphere and 5% CO2 (50) . Virus titrations were performed in duplicate after sonication and were standardized to cell numbers. Thus, virus titers per milliliter represented the virus production by ca. 3 x 105 lymphocytes. Infectious-center assays were performed by a modification of a method described previously (6) . In (6) . Briefly, T lymphocytes tagged with the respective monoclonal antibody were incubated overnight at 4°C with ox erythrocytes coated with anti-mouse IgG via CrCl2 linkage (37 F(ab')2 fragments of antibodies were prepared by pepsin digestion as described previously (7) . These F(ab')2 fragments were additionally used for IFT. Double-immunofluorescence experiments were done in the same way as IFT experiments, with additional incubation of the cells with a rabbit anti-HCMV antibody or human reconvalescence serum in combination with a tetramethyl rhodaminisothiocyanate-labeled swine anti-rabbit or anti-human IgG F(ab')2 fragment, respectively. Mock-infected stimulated and nonstimulated lymphocytes served as a control. Nonspecific reactivity of monoclonal anti-lymphocyte antibodies with HCMV proteins was excluded by IFT on HCMV-infected Wi-38 cells. The monoclonal antibodies OKT3, OKT4, and OKT8 were purchased from Ortho Diagnostics, Heidelberg.
Western blot. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed essentially as described by Thomas and Kornberg (46) . Lymphocytes (ca. 3 x 105 cells) were washed three times in Tris-buffered saline (TBS; 0.05 M Tris hydrochloride [pH 7.4], 0.15 M NaCl) and boiled for 3 min in sample buffer (0.0625 M Tris hydrochloride [pH 6.8], 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.001% bromphenol blue). Polyacrylamide gels (10%) were run as 1.5-mm slab gels. Internal molecular weight standards were carboanhydrase (29 000), ovalbumin (45 000), albumin (66 000) and phosphorylase b (97 400), all purchased from New England Nuclear Corp., Dreieich, Federal Republic of Germany.
After electrophoretic separation, proteins were electrophoretically transferred to nitrocellulose sheets as described by Towbin et al. (49) . Nitrocellulose sheets were washed in 26, 42) . The DNA of lymphocytes was prepared by treatexperiments were pCM3, PCM52, pCM104, and pCM5002. ment of cells with 1% sarcosyl and subsequent digestion with Recombinant plasmid DNA was obtained by lysozyme treatproteinase K (200 ,ug/ml). Subsequently, the cellular DNA ment of transformed bacteria, phenol extraction of DNA, was purified by phenol-chloroform and chloroform-isoamyl and subsequent centrifugation in cesium chloride-EtBr graalcohol extraction, precipitated with 80% ethanol, washed, dients as comprehensively described by Maniatis et al. (25) . and suspended in distilled water (25) . The DNA concentraWashing conditions for blots were 4 x 5 min in 2 x tion and purity was calculated by measurement of the optical SSC-0.1% SDS at room temperature and 3 h in 0.2 x density at 260 and 280 nm. Only DNA with an optical density SSC-0. 1% SDS at 680C. Subsequently, filters were dried and ratio (260 nm/280 nm) of more than 1.75 was used in further exposed to XAR-5 films (Eastman-Kodak). Southern bTn, Days (n) after infection.
C ND, Not done.
MOI of 5 and, after infection, were thoroughly washed. MLC, however, about 50% of cultures did produce infecVirus replication was monitored by plaque titration for 20 tious progeny virus between days 11 and 13 after infection, days. None of the HCMV-infected leukocyte subsets sup- although to low titers. The ability of T-cell cultures to ported virus replication under the specified conditions, resupport the growth of HCMV apparently was not dependent gardless of the mode of stimulation ( (1, 24) . T lymphowere determined daily by plaque titration for 20 days. The cytes were stimulated in both variants. T cells stimulated in T-cell cultures grown with IL-2 did support virus replication, the autologous MLC did not replicate HCMV (Table 2) . whereas no progeny virus was found in cultures grown When T lymphocytes were stimulated in the heterologous without the addition of IL-2 (Table 3) . Infectious center Replication of HCMV in CTC and T-cell lines. The results obtained by the addition of IL-2 to HCMV-infected stimulated T cells indicated a crucial role of IL-2 in the permissiveness of human T lymphocytes to HCMV. To prove the ability of CTC to replicate HCMV, PHA-stimulated T cells that had been held in IL-2 for 10 days were infected with HCMV strain AD169 at an MOI of 5. All of these T-cell cultures were able to replicate HCMV (Table 4) . Virus titers in general increased between 12 and 14 days after infection and reached peak titers of 103 PFU/ml. Infectious center assays again revealed about 0.08% virus-replicating cells. In contrast, the same cells stimulated merely by PHA did not show virus replication. Virus replication was also not found in the human T-cell lines MOLT 4 and JM (data not shown), indicating that rapid cellular DNA synthesis alone is not sufficient to acquire permissiveness for HCMV infection.
To analyze the viral protein synthesis in HCMV-infected CTC, Western blot experiments were performed by a highly sensitive technique combining the use of biotinylated second antibody and streptavidin-peroxidase complexes. Expression of a 68-and a 52-kDa HCMV protein was detected in CTC at 6 and 12 days after infection (Fig. 1) . In contrast, no such proteins could be demonstrated in mock-infected CTC, mock-infected PHA lymphoblasts, or HCMV-infected PHAstimulated lymphoblasts. In CTC, however, in contrast to PHA-stimulated T cells, two additional bands at 70 and 72 kDa were observed. These were, however, not virus specific, since they were also visible in mock-infected CTC. Most likely, these bands were reacting with the diaminobenzidine tetrahydrochloride staining itself and presented cellular cytochromic proteins. Further experiments to immunoprecipitate the respective viral late proteins from lysates of HCMV-infected CTC, however, failed. As well as the difficulty in specifically analyzing proteins which are expressed only on a minority of members of a cell population, this failure might be caused by the fact that the maintenance of CTC in an almost methionine-deficient medium for more than 1 week is difficult and results in a rapid loss of cell viability (data not shown). Viral DNA synthesis as determined by dot-blot experiments and hybridization to cloned HCMV fragments could also be demonstrated in CTC, but not in PHA-stimulated control cultures. Peaks of viral DNA synthesis were reached on days 8 and 12 after infection ( Fig. 2A) . At day 16 postinfection, viral DNA synthesis reached control levels again. By cocultivation with HEL cells, however, virus could be isolated from CTC up to day 28 postinfection (data not shown). To further exclude the possibility that the observed increase in virus titers was due to the reactivation of latent virus from the isolated lymphocytes, Southern blot experiments were performed to compare the restriction endonuclease pattern of our standard HCMV strain AD 169 with the pattern of the virus isolated from the infected lymphocytes. Both viruses represented the same restriction pattern after digestion with the endonuclease EcoRI (Fig.   2C ).
Immunofluorescence studies on HCMV-infected T cells. To assess the expression of EA and late antigen (LA) in PHA-stimulated T cells and CTC, IFT studies with a monoclonal antibody against HCMV EA, a rabbit antibody against LA, and human reconvalescence serum were performed. Expression of EA and LA was not detected in mitogenstimulated T and B cells, but was found in CTC, in which ca. 8% of cells expressed EA and 1% expressed LA ( undertaken. Results of these experiments as displayed in Table 5 and Fig. 3 define the HCMV-replicating T-cell subset as preferentially consisting of OKT3+ and OKT8+ cells, suggesting that a subset of the T-suppressor-cytotoxic cells is possibly involved in HCMV replication. To further exclude that some of the HCMV-positive cells observed in IFT were nonspecifically stained by Fc binding of antibodies, double-immunofluorescence experiments were undertaken with F(ab')2 fragments of antibodies obtained by pepsin digestion. Results of these experiments, as also shown in Fig. 3 , confirmed the data obtained by conventional double immunofluorescence.
Replication of HCMV in purified OKT4+ and OKT8+ cells. To further determine which of the known T-cell subsets are in principle susceptible to HCMV infection, we preparatively separated OKT4+ and OKT8+ cells by indirect rosetting. Both cell populations after stimulation with IL-2 did produce infectious progeny virus in titers comparable to the OKT3+ lymphocyte population (Table 4) . Moreover, viral DNA synthesis was also found in both cell populations, as determined by dot-blot analysis (Fig. 2B) . However, as indicated again by infectious center assays and IFT, only a subset not exceeding 0.1% of these cells participated in active virus production ( (12) . The observed 68-kDa protein, however, may rather correspond to the major capsid protein of HCMV, which is an abundant protein in the virion and in HCMVinfected cells (27) . (38) , cannot be excluded by these data.
In preparatively separated OKT4+ and OKT8+ cells, replication of HCMV was found in both T-cell subsets, as determined by virus titration, infectious-center assays, and analysis of DNA replication. It is noteworthy that also in these separated T-cell subsets, replication of HCMV was restricted to a tiny subset of cells not exceeding 0.1%, suggesting that T cells permissive for HCMV infection may be characterized by additional markers. In this context, the data of Rice et al. (31) , which showed the expression of viral immediate-early genes in a minor subset of OKT4+ and OKT8+ cells, should also be noted. Moreover, Schrier et al. (28) . We thus addressed the question of whether endogenous virus may be reactivated by stimulation of T cells with IL-2. This, however, seems to be unlikely. Thus, no such reactivation was observed in mock-infected CTC and DNA from HCMV strain AD169, and DNA from virus recovered from infected CTC showed an identical restriction pattern. Furthermore, most of the buffy coats used were derived from donors seronegative for HCMV.
We have found that HCMV replication does not take place in T-cell cultures stimulated in the autologous MLC, but does occur in 50% of T-cell cultures stimulated in the allogeneic MLC irrespective of the serological state of the donor. For the replication of herpes simplex virus in human T cells this has been similarly described (6, 17) . It was noted that the stimulation index of replicating cultures 10 days postinfection was in general higher than in cultures restricting virus replication. In this context, St. Jeor and Hutt (44) showed that cell replication is a prerequisite for the replication of HCMV, and this may also hold true for the lymphocyte system. The reason for the stimulation differences in replicating and abortively infected T-cell cultures remains to be established, but may be related, however, to impaired IL-2 production in the latter. In these cultures the failure to replicate HCMV could be restored by the addition of IL-2 after infection. The importance of IL-2 in the activation of HCMV-replicating T cells was further documented by the finding that in contrast to CTC, T cells or T-cell lines stimulated only by PHA did not support virus replication, indicating that mitogen stimulation or rapid DNA synthesis alone is not sufficient for the acquirement of permissiveness of T cells to HCMV infection. This permissiveness rather requires a certain step of cellular differentiation, as previously shown for other CMV systems (10, 16) .
As shown by dot-blot analysis and IFT experiments with antibodies against EA, the restriction of virus replication in abortively infected cultures appears to be already at a level before early gene expression, supporting the data of Einhorn and Ost (11) and Rice et al. (31) , who found expression of EAs and immediate-early antigens, respectively, in human blood cells only with wild-type strains of HCMV, but not with the established laboratory strains such as HCMV strain AD169.
In the literature it is widely held that HCMV may be frequently isolated from polymorphonuclear cells of acutely infected patients (22) . It was not clear, however, whether this is due to virus replication in these cells or is rather a result of a nonspecific uptake of virus, which is also suggested by the data of Rinaldo et al., who did not find alterations in granulocyte function in HCMV-infected patients (33) . The data presented here support the latter theory, especially since we did not observe HCMV replication when dimethyl sulfoxide-differentiated HL-60 cells were infected (data not shown). The isolation of cytomegalovirus, however, has also been reported from monocytes and mouse B cells, and it was shown that only wild-type strains of HCMV were able to induce immediate-early protein expression in monocytes, NK cells, B lymphocytes, and OKT4+ and OKT8+ cells (31) . Similarly, we did not find expression of EA in HCMV strain AD169-infected mitogen-stimulated T cells, nor did we find evidence for virus replication in any of these cell populations. It might well be possible, however, that by appropriate stimulation or under in vivo conditions, these cells actively take part in vitro replication.
Little is known about latency and reactivation of HCMV in man. The finding that HCMV could be isolated from HCMV-infected CTC as late as 4 weeks after infection and was replicated by previously infected T cells upon IL-2 stimulation may now allow the establishment of a latency system; this will be studied in the near future.
